For detailedTolerabilityHelp promote a better infusion experience
GAMMAGARD LIQUID therapy is formulated to address a wide range of patient needs and to help improve tolerability.
NO added sugars1
- Sucrose-free formula for patients at risk of kidney dysfunction
- No added glucose or any other sugars, which may make it a good choice for patients with diabetes
NO added sodium1
- May be appropriate for patients who should restrict their sodium intake
NO added preservatives1
- May be appropriate for patients who have difficulty tolerating some preservatives
NO latex in the packaging1
- May be appropriate for patients who have allergic reactions to latex
GAMMAGARD LIQUID [Immune Globulin Intravenous(Human)] 10% has an osmolality of 240 - 300 mOsmol/kg, which is similar to physiological osmolality.1
GAMMAGARD LIQUID [Immune Globulin Intravenous (Human)] 10% has a low pH of 4.6–5.1.1 Research shows that low pH levels of IVIGs can lower dimers and aggregates.2
Please see the detailed Important Risk Information and Full Prescribing Information for GAMMAGARD LIQUID [Immune Globulin Intravenous (Human)] for full prescribing details.
- GAMMAGARD LIQUID [Immune Globulin Intravenous (Human)] 10% package insert. Westlake Village, CA. Baxter International Inc.; October 2009.
- Kroez M, Kanzy EJ, Gronski P, Dickneite G. Hypotension with intranvenous immunoglobulin therapy: importance of pH and dimmer formation . Biologicals. 2003;31:277-286.
